FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000729699> ?p ?o ?g. }

• W2000729699 endingPage "e0119260" @default.
• W2000729699 startingPage "e0119260" @default.
• W2000729699 abstract "Background Patients undergoing anti-tumor necrosis factor (TNF) treatment are at an increased risk of reactivating a latent tuberculosis infection (LTBI). This study evaluated the effectiveness of the QuantiFERON-TB Gold In-Tube (QFT) assay for diagnosing LTBI in arthritis patients undergoing anti-TNF treatment. Methods We enrolled 342 consecutive patients from August 2007 to October 2013: 176 (51.5%) patients with ankylosing spondylitis and 166 (48.5%) with rheumatoid arthritis. Screening tests included tuberculin skin test (TST) and QFT assay. Positive QFT results, regardless of TST results, were considered an indicator for LTBI treatment. Results Bacillus Calmette-Guérin scars were found in 236 (69.0%) patients. Of 342 patients, TST and QFT were positive in 122 (35.7%) and 103 (30.1%) patients, respectively, and discordant in 101 (29.5%) patients. During a median follow-up duration of 41.7 months, five patients (1.5%) developed TB in a median of 20.8 months after initiation of anti-TNF treatment (428/100,000 person-years). TB did not occur in 62 TST+/QFT+ patients who received LTBI treatment. Of 41 TST−/QFT+ patients who received LTBI treatment, one (2.4%) developed TB 20.5 months after starting anti-TNF treatment (705/100,000 person-years). Of 60 TST+/QFT− patients who did not receive LTBI treatment, two (3.3%) developed TB 20.8 and 22.0 months after starting anti-TNF treatment (871/100,000 person-years). Of 179 TST−/QFT− patients, two (1.1%) developed TB 7.2 and 22.7 months, respectively, after initiating anti-TNF treatment (341/100,000 person-years). TB incidence rate during the follow-up period did not differ among TST−/QFT+, TST+/QFT−, and TST−/QFT− patients (P = 0.661). Conclusion QFT might be used instead of TST for diagnosing LTBI in patients before starting anti-TNF therapy in countries, such as Korea, where the TB prevalence is intermediate and the BCG vaccination is mandatory at birth. In the absence of a true gold standard test for LTBI, however, there is still a risk of TB development during anti-TNF treatment." @default.
• W2000729699 created "2016-06-24" @default.
• W2000729699 creator A5011892284 @default.
• W2000729699 creator A5013938534 @default.
• W2000729699 creator A5032320239 @default.
• W2000729699 creator A5063002351 @default.
• W2000729699 creator A5071811721 @default.
• W2000729699 creator A5074854197 @default.
• W2000729699 creator A5081925096 @default.
• W2000729699 creator A5083718698 @default.
• W2000729699 creator A5085504469 @default.
• W2000729699 creator A5090050510 @default.
• W2000729699 date "2015-03-06" @default.
• W2000729699 modified "2023-10-16" @default.
• W2000729699 title "QuantiFERON-TB Gold In-Tube Assay for Screening Arthritis Patients for Latent Tuberculosis Infection before Starting Anti-Tumor Necrosis Factor Treatment" @default.
• W2000729699 cites W1761300068 @default.
• W2000729699 cites W1840098159 @default.
• W2000729699 cites W1965567508 @default.
• W2000729699 cites W1966756689 @default.
• W2000729699 cites W1974648640 @default.
• W2000729699 cites W1978001480 @default.
• W2000729699 cites W1985860622 @default.
• W2000729699 cites W1994620306 @default.
• W2000729699 cites W2008789811 @default.
• W2000729699 cites W2013829686 @default.
• W2000729699 cites W2020050449 @default.
• W2000729699 cites W2038535814 @default.
• W2000729699 cites W2043034224 @default.
• W2000729699 cites W2044846394 @default.
• W2000729699 cites W2049439978 @default.
• W2000729699 cites W2052522160 @default.
• W2000729699 cites W2055651610 @default.
• W2000729699 cites W2070353058 @default.
• W2000729699 cites W2073312789 @default.
• W2000729699 cites W2076949124 @default.
• W2000729699 cites W2085318733 @default.
• W2000729699 cites W2088932602 @default.
• W2000729699 cites W2090675997 @default.
• W2000729699 cites W2096321772 @default.
• W2000729699 cites W2097362715 @default.
• W2000729699 cites W2100125044 @default.
• W2000729699 cites W2100736304 @default.
• W2000729699 cites W2111033751 @default.
• W2000729699 cites W2111626127 @default.
• W2000729699 cites W2122316162 @default.
• W2000729699 cites W2127681731 @default.
• W2000729699 cites W2131278746 @default.
• W2000729699 cites W2131999276 @default.
• W2000729699 cites W2135717214 @default.
• W2000729699 cites W2141090053 @default.
• W2000729699 cites W2142165025 @default.
• W2000729699 cites W2144097480 @default.
• W2000729699 cites W2151922469 @default.
• W2000729699 cites W2152348310 @default.
• W2000729699 cites W2154501022 @default.
• W2000729699 cites W2159161724 @default.
• W2000729699 cites W2169914783 @default.
• W2000729699 cites W2171507595 @default.
• W2000729699 cites W2273875723 @default.
• W2000729699 cites W2325603769 @default.
• W2000729699 cites W2394848554 @default.
• W2000729699 cites W4247135939 @default.
• W2000729699 cites W86096242 @default.
• W2000729699 doi "https://doi.org/10.1371/journal.pone.0119260" @default.
• W2000729699 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4352032" @default.
• W2000729699 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25746854" @default.
• W2000729699 hasPublicationYear "2015" @default.
• W2000729699 type Work @default.
• W2000729699 sameAs 2000729699 @default.
• W2000729699 citedByCount "24" @default.
• W2000729699 countsByYear W20007296992015 @default.
• W2000729699 countsByYear W20007296992016 @default.
• W2000729699 countsByYear W20007296992017 @default.
• W2000729699 countsByYear W20007296992018 @default.
• W2000729699 countsByYear W20007296992019 @default.
• W2000729699 countsByYear W20007296992020 @default.
• W2000729699 countsByYear W20007296992021 @default.
• W2000729699 countsByYear W20007296992022 @default.
• W2000729699 countsByYear W20007296992023 @default.
• W2000729699 crossrefType "journal-article" @default.
• W2000729699 hasAuthorship W2000729699A5011892284 @default.
• W2000729699 hasAuthorship W2000729699A5013938534 @default.
• W2000729699 hasAuthorship W2000729699A5032320239 @default.
• W2000729699 hasAuthorship W2000729699A5063002351 @default.
• W2000729699 hasAuthorship W2000729699A5071811721 @default.
• W2000729699 hasAuthorship W2000729699A5074854197 @default.
• W2000729699 hasAuthorship W2000729699A5081925096 @default.
• W2000729699 hasAuthorship W2000729699A5083718698 @default.
• W2000729699 hasAuthorship W2000729699A5085504469 @default.
• W2000729699 hasAuthorship W2000729699A5090050510 @default.
• W2000729699 hasBestOaLocation W20007296991 @default.
• W2000729699 hasConcept C126322002 @default.
• W2000729699 hasConcept C141071460 @default.
• W2000729699 hasConcept C142724271 @default.
• W2000729699 hasConcept C2776247216 @default.
• W2000729699 hasConcept C2776260265 @default.
• W2000729699 hasConcept C2776763545 @default.
• W2000729699 hasConcept C2777077863 @default.

• next